UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION Washington, D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of
Report (Date of earliest event reported)
May 19,
2005
Bovie
Medical Corporation
(Exact
name of registrant as specified in its
charter)
Delaware |
0-12183 |
11-2644611 |
(State
or other jurisdiction
Of
incorporation or organization) |
(Commission
File
Number) |
(IRS
Employer Identification No.) |
734 Walt Whitman Road, Melville, New York
11747
(Address
of principal executive offices) (Zip
Code)
Registrant's
telephone number, including area code
(631)
421-5452
N/A
(Former
name or former address, if changed since last report.)
Check the
appropriate box below if the Form 8-K filing is intended to
simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
[ ]
Written communications pursuant to Rule 425 under the Securities Act 17 CFR
230.425)
[ ]
Soliciting material pursuant to Rule l4a-12 under the Exchange Act
(17 CFR
240.l4a-12)
[ ]
Pre-commencement communications pursuant to Rule l4d- 2(b) under the Exchange
Act (17 CFR 240. l4d- 2(b)
[ ]
Pre-commencement communications pursuant to Rule 13 e-4( c) under the Exchange
Act (17 CFR 240.13 e-4( c)
Item
5.02. Departure of Directors or Principal Officers; Election of Directors;
Appointment of Principal Officers
On May
19, 2005, and effective immediately, Alfred V. Greco resigned as a director of
Bovie Medical Corporation (the “Company”) for personal reasons. A copy of Mr.
Greco’s letter of resignation is attached as an exhibit to this Form 8-K Current
Report.
EXHIBITS:
17. |
Letter
of Resignation of Alfred V. Greco dated May 19,
2005 |
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Date: May
25, 2005
|
/s/
Andrew Makrides |
|
President,
Chief |
|
Executive
Officer, Chairman |
|
of
the Board and Director |